Alvaro Cobo Calvo Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Email Alvaro Cobo Calvo Email Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca
Projects Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a first demyelinating syndrome IP: Alvaro Cobo Calvo Collaborators: Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a , Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 119567 Reference: FI21/00282 Duration: 01/01/2022 - 31/12/2025 Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a first demyelinating syndrome IP: Alvaro Cobo Calvo Collaborators: Rosalia Horno Ocaña, Cristina Auger Acosta, Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a , Luciana Midaglia Fernandez, Breogan Rodriguez Acevedo, Mireia Castillo Juarez Funding agency: Instituto de Salud Carlos III Funding: 134915 Reference: PI20/00800 Duration: 01/01/2021 - 30/06/2025 Utilidad de biomarcadores de suero y líquido cefalorraquídeo en la evaluación del pronóstico y respuesta a tratamiento en pacientes con fases iniciales de Esclerosis Multiple IP: Manuel Comabella Lopez Collaborators: Alvaro Cobo Calvo, Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 180000 Reference: JR19/00007 Duration: 01/01/2020 - 31/12/2023 Pagination First page « Previous page ‹ Page 1 Current page 2
